companydata.dkG2B BioSolutions ApS: Financial statements 2024
CVR: 42437069
G2B BioSolutions ApS (CVR 42437069) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 435,674 and a net result of DKK 370,740 compared with DKK -1,513,784 the year before. Equity amounted to DKK -1,350,236. The company had 1 employee in the financial year.
- Gross Profit
- 435,674 kr.
- Profit/Loss
- 370,740 kr.
- Equity
- -1,350,236 kr.
- Total Assets
- 591,900 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 436 t. | 371 t. | -1.4 mio. | 1 |
| 2023 | - | -740 t. | -1.5 mio. | -1.7 mio. | 2 |
| 2022 | - | -171 t. | -219 t. | -207 t. | 1 |
How creditworthy is G2B BioSolutions ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
G2B BioSolutions ApS has published its annual report for 2023. Gross profit came to DKK -739,652, and the net result was DKK -1,513,784.
About G2B BioSolutions ApS
G2B BioSolutions ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dayanand Suryabhan Jadhav. The company is owned by Dayanand Jadhav Holding ApS. In 2025, the company reported a gross profit of DKK 44,817 and a net result of DKK 136,864 compared with DKK 370,740 the year before. Equity amounted to DKK -1,213,372.